Penumbra, Inc.
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PEN moving today?
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PEN overview
Related filings and maps
Congress activity in PEN
No receipt-qualified Congressional disclosure is present for PEN in the cached public ledger.
PEN contract awards, year to date.
Public federal awards linked to this ticker.
PEN lobbying filings, year to date.
Registered lobbying filings matched to Penumbra, Inc..